PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 56 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $524,000 | -63.1% | 110,400 | -54.6% | 0.00% | -100.0% |
Q4 2017 | $1,419,000 | +177.7% | 243,400 | 0.0% | 0.00% | – |
Q3 2017 | $511,000 | -55.1% | 243,400 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $1,139,000 | -40.1% | 243,400 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,903,000 | -51.9% | 243,400 | -24.5% | 0.00% | -50.0% |
Q4 2016 | $3,953,000 | -59.4% | 322,400 | -48.4% | 0.00% | -60.0% |
Q3 2016 | $9,744,000 | +28.5% | 625,000 | 0.0% | 0.01% | +25.0% |
Q2 2016 | $7,581,000 | – | 625,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBOURVEST PARTNERS LLC | 440,627 | $2,093,000 | 2.25% |
NEA Management Company, LLC | 5,556,778 | $26,395,000 | 1.17% |
Endurant Capital Management LP | 472,012 | $2,242,000 | 0.84% |
DAFNA Capital Management LLC | 267,100 | $1,269,000 | 0.62% |
RTW INVESTMENTS, LP | 1,104,940 | $5,248,000 | 0.50% |
DOHENY ASSET MANAGEMENT /CA | 69,625 | $331,000 | 0.17% |
BAILARD, INC. | 520,100 | $2,470,000 | 0.16% |
Bain Capital Public Equity Management, LLC | 399,947 | $1,900,000 | 0.14% |
Rock Springs Capital Management LP | 675,000 | $3,206,000 | 0.14% |
Hillhouse Capital Management | 865,923 | $4,113,000 | 0.07% |